APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Milk Oligosaccharides (HMO)

Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan’s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces. Human milk oligosaccharides are manufactured through numerous processes which involve the use of several chemicals, enzymes or microbes. The technology used for manufacturing of human milk oligosaccharides is very complex and expensive, thus restricting their large-scale production. Major players have been increasing investing increasingly on R&D for low-cost production and the introduction of effective technologies for product synthesis.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan’s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces. Human milk oligosaccharides are manufactured through numerous processes which involve the use of several chemicals, enzymes or microbes. The technology used for manufacturing of human milk oligosaccharides is very complex and expensive, thus restricting their large-scale production. Major players have been increasing investing increasingly on R&D for low-cost production and the introduction of effective technologies for product synthesis.

Selected research

Industry Growth & Trends

Global Human Milk Oligosaccharides (HMO) Industry Growth and Trends Forecast to 2032

8 January 202699 pages

Choose your research edition.

Industry ResearchHuman Milk Oligosaccharides (HMO) Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Milk Oligosaccharides (HMO) Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Human Milk Oligosaccharides (HMO) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Milk Oligosaccharides (HMO) Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Milk Oligosaccharides (HMO) Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan’s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces. Human milk oligosaccharides are manufactured through numerous processes which involve the use of several chemicals, enzymes or microbes. The technology used for manufacturing of human milk oligosaccharides is very complex and expensive, thus restricting their large-scale production. Major players have been increasing investing increasingly on R&D for low-cost production and the introduction of effective technologies for product synthesis.

Global core Human Milk Oligosaccharides (HMO) manufacturers include Abbott, Glycom etc.The top 2 companies hold a share about 70%.North America is the largest market, with a share about 50%, followed by Europe and Asia Pacific with the share about 34% and 14%.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Human Milk Oligosaccharides (HMO) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Human Milk Oligosaccharides (HMO) market size, estimates, and forecasts are presented in terms of sales volume (Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Human Milk Oligosaccharides (HMO) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Human Milk Oligosaccharides (HMO).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Human Milk Oligosaccharides (HMO) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Human Milk Oligosaccharides (HMO) Market by Company

Abbott

Inbiose

Glycom

Chr. Hansen (Jennewein)

Elicityl SA

ZuChem

Dextra Laboratories

Human Milk Oligosaccharides (HMO) Segment by Type

2'-FL & 3-FL

Sialyllactose

LNT & LNnT

Human Milk Oligosaccharides (HMO) Segment by Application

Infant Formula

Functional Food & Beverages

Food/Medical Supplements

Others

Human Milk Oligosaccharides (HMO) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Milk Oligosaccharides (HMO) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Milk Oligosaccharides (HMO) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Milk Oligosaccharides (HMO).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Human Milk Oligosaccharides (HMO) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Human Milk Oligosaccharides (HMO) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 2'-FL & 3-FL Table 2. Major Company of Sialyllactose Table 3. Major Company of LNT & LNnT Table 4. Global Human Milk Oligosaccharides (HMO) Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Human Milk Oligosaccharides (HMO) Sales by Type (2021-2026) & (Tons) Table 6. Global Human Milk Oligosaccharides (HMO) Sales Market Share in Volume by Type (2021-2026) Table 7. Global Human Milk Oligosaccharides (HMO) Sales by Type (2021-2026) & (US$ Million) Table 8. Global Human Milk Oligosaccharides (HMO) Sales Market Share in Value by Type (2021-2026) Table 9. Global Human Milk Oligosaccharides (HMO) Price by Type (2021-2026) & (USD/Ton) Table 10. Global Human Milk Oligosaccharides (HMO) Sales by Type (2027-2032) & (Tons) Table 11. Global Human Milk Oligosaccharides (HMO) Sales Market Share in Volume by Type (2027-2032) Table 12. Global Human Milk Oligosaccharides (HMO) Sales by Type (2027-2032) & (US$ Million) Table 13. Global Human Milk Oligosaccharides (HMO) Sales Market Share in Value by Type (2027-2032) Table 14. Global Human Milk Oligosaccharides (HMO) Price by Type (2027-2032) & (USD/Ton) Table 15. North America Human Milk Oligosaccharides (HMO) Sales by Type (2021-2026) & (Tons) Table 16. North America Human Milk Oligosaccharides (HMO) Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Human Milk Oligosaccharides (HMO) Sales by Type (2021-2026) & (Tons) Table 18. Europe Human Milk Oligosaccharides (HMO) Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Human Milk Oligosaccharides (HMO) Sales by Type (2021-2026) & (Tons) Table 20. Asia-Pacific Human Milk Oligosaccharides (HMO) Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Human Milk Oligosaccharides (HMO) Sales by Type (2021-2026) & (Tons) Table 22. Latin America Human Milk Oligosaccharides (HMO) Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Human Milk Oligosaccharides (HMO) Sales by Type (2021-2026) & (Tons) Table 24. Middle East and Africa Human Milk Oligosaccharides (HMO) Sales by Type (2021-2026) & (US$ Million) Table 25. Human Milk Oligosaccharides (HMO) Industry Trends Table 26. Human Milk Oligosaccharides (HMO) Industry Drivers Table 27. Human Milk Oligosaccharides (HMO) Industry Opportunities and Challenges Table 28. Human Milk Oligosaccharides (HMO) Industry Restraints Table 29. Global Human Milk Oligosaccharides (HMO) Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Company (2021-2026) Table 31. Global Human Milk Oligosaccharides (HMO) Sales by Company (2021-2026) & (Tons) Table 32. Global Human Milk Oligosaccharides (HMO) Sales Share by Company (2021-2026) Table 33. Global Human Milk Oligosaccharides (HMO) Market Price by Company (2021-2026) & (USD/Ton) Table 34. Global Human Milk Oligosaccharides (HMO) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Human Milk Oligosaccharides (HMO) Major Company Production Sites and Headquarters Table 36. Global Human Milk Oligosaccharides (HMO) Company, Product Type & Application Table 37. Global Human Milk Oligosaccharides (HMO) Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Human Milk Oligosaccharides (HMO) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Human Milk Oligosaccharides (HMO) Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Human Milk Oligosaccharides (HMO) Sales by Region (2021-2026) & (Tons) Table 42. Global Human Milk Oligosaccharides (HMO) Sales Market Share in Volume by Region (2021-2026) Table 43. Global Human Milk Oligosaccharides (HMO) Sales by Region (2021-2026) & (US$ Million) Table 44. Global Human Milk Oligosaccharides (HMO) Sales Market Share in Value by Region (2021-2026) Table 45. Global Human Milk Oligosaccharides (HMO) Sales (Tons), Value (US$ Million), Price (USD/Ton) and Gross Margin (2021-2026) Table 46. Global Human Milk Oligosaccharides (HMO) Sales by Region (2027-2032) & (Tons) Table 47. Global Human Milk Oligosaccharides (HMO) Sales Market Share in Volume by Region (2027-2032) Table 48. Global Human Milk Oligosaccharides (HMO) Sales by Region (2027-2032) & (US$ Million) Table 49. Global Human Milk Oligosaccharides (HMO) Sales Market Share in Value by Region (2027-2032) Table 50. Global Human Milk Oligosaccharides (HMO) Sales (Tons), Value (US$ Million), Price (USD/Ton) and Gross Margin (2027-2032) Table 51. Global Human Milk Oligosaccharides (HMO) Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Human Milk Oligosaccharides (HMO) Sales by Application (2021-2026) & (Tons) Table 53. Global Human Milk Oligosaccharides (HMO) Sales Market Share in Volume by Application (2021-2026) Table 54. Global Human Milk Oligosaccharides (HMO) Sales by Application (2021-2026) & (US$ Million) Table 55. Global Human Milk Oligosaccharides (HMO) Sales Market Share in Value by Application (2021-2026) Table 56. Global Human Milk Oligosaccharides (HMO) Price by Application (2021-2026) & (USD/Ton) Table 57. Global Human Milk Oligosaccharides (HMO) Sales by Application (2027-2032) & (Tons) Table 58. Global Human Milk Oligosaccharides (HMO) Sales Market Share in Volume by Application (2027-2032) Table 59. Global Human Milk Oligosaccharides (HMO) Sales by Application (2027-2032) & (US$ Million) Table 60. Global Human Milk Oligosaccharides (HMO) Sales Market Share in Value by Application (2027-2032) Table 61. Global Human Milk Oligosaccharides (HMO) Price by Application (2027-2032) & (USD/Ton) Table 62. North America Human Milk Oligosaccharides (HMO) Sales by Application (2021-2026) & (Tons) Table 63. North America Human Milk Oligosaccharides (HMO) Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Human Milk Oligosaccharides (HMO) Sales by Application (2021-2026) & (Tons) Table 65. Europe Human Milk Oligosaccharides (HMO) Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Human Milk Oligosaccharides (HMO) Sales by Application (2021-2026) & (Tons) Table 67. Asia-Pacific Human Milk Oligosaccharides (HMO) Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Human Milk Oligosaccharides (HMO) Sales by Application (2021-2026) & (Tons) Table 69. Latin America Human Milk Oligosaccharides (HMO) Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Human Milk Oligosaccharides (HMO) Sales by Application (2021-2026) & (Tons) Table 71. Middle East and Africa Human Milk Oligosaccharides (HMO) Sales by Application (2021-2026) & (US$ Million) Table 72. Abbott Company Information Table 73. Abbott Business Overview Table 74. Abbott Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2021-2026) Table 75. Abbott Human Milk Oligosaccharides (HMO) Product Portfolio Table 76. Abbott Recent Development Table 77. Inbiose Company Information Table 78. Inbiose Business Overview Table 79. Inbiose Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2021-2026) Table 80. Inbiose Human Milk Oligosaccharides (HMO) Product Portfolio Table 81. Inbiose Recent Development Table 82. Glycom Company Information Table 83. Glycom Business Overview Table 84. Glycom Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2021-2026) Table 85. Glycom Human Milk Oligosaccharides (HMO) Product Portfolio Table 86. Glycom Recent Development Table 87. Chr. Hansen (Jennewein) Company Information Table 88. Chr. Hansen (Jennewein) Business Overview Table 89. Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2021-2026) Table 90. Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Product Portfolio Table 91. Chr. Hansen (Jennewein) Recent Development Table 92. Elicityl SA Company Information Table 93. Elicityl SA Business Overview Table 94. Elicityl SA Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2021-2026) Table 95. Elicityl SA Human Milk Oligosaccharides (HMO) Product Portfolio Table 96. Elicityl SA Recent Development Table 97. ZuChem Company Information Table 98. ZuChem Business Overview Table 99. ZuChem Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2021-2026) Table 100. ZuChem Human Milk Oligosaccharides (HMO) Product Portfolio Table 101. ZuChem Recent Development Table 102. Dextra Laboratories Company Information Table 103. Dextra Laboratories Business Overview Table 104. Dextra Laboratories Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2021-2026) Table 105. Dextra Laboratories Human Milk Oligosaccharides (HMO) Product Portfolio Table 106. Dextra Laboratories Recent Development Table 107. North America Human Milk Oligosaccharides (HMO) Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 108. North America Human Milk Oligosaccharides (HMO) Sales by Country (2021-2026) & (Tons) Table 109. North America Human Milk Oligosaccharides (HMO) Sales Market Share by Country (2021-2026) Table 110. North America Human Milk Oligosaccharides (HMO) Sales Forecast by Country (2027-2032) & (Tons) Table 111. North America Human Milk Oligosaccharides (HMO) Sales Market Share Forecast by Country (2027-2032) Table 112. North America Human Milk Oligosaccharides (HMO) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 113. North America Human Milk Oligosaccharides (HMO) Market Size by Country (2021-2026) & (US$ Million) Table 114. North America Human Milk Oligosaccharides (HMO) Market Share by Country (2021-2026) Table 115. North America Human Milk Oligosaccharides (HMO) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 116. North America Human Milk Oligosaccharides (HMO) Market Share Forecast by Country (2027-2032) Table 117. Europe Human Milk Oligosaccharides (HMO) Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 118. Europe Human Milk Oligosaccharides (HMO) Sales by Country (2021-2026) & (Tons) Table 119. Europe Human Milk Oligosaccharides (HMO) Sales Market Share by Country (2021-2026) Table 120. Europe Human Milk Oligosaccharides (HMO) Sales Forecast by Country (2027-2032) & (Tons) Table 121. Europe Human Milk Oligosaccharides (HMO) Sales Market Share Forecast by Country (2027-2032) Table 122. Europe Human Milk Oligosaccharides (HMO) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 123. Europe Human Milk Oligosaccharides (HMO) Market Size by Country (2021-2026) & (US$ Million) Table 124. Europe Human Milk Oligosaccharides (HMO) Market Share by Country (2021-2026) Table 125. Europe Human Milk Oligosaccharides (HMO) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 126. Europe Human Milk Oligosaccharides (HMO) Market Share Forecast by Country (2027-2032) Table 127. Asia-Pacific Human Milk Oligosaccharides (HMO) Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 128. Asia-Pacific Human Milk Oligosaccharides (HMO) Sales by Country (2021-2026) & (Tons) Table 129. Asia-Pacific Human Milk Oligosaccharides (HMO) Sales Market Share by Country (2021-2026) Table 130. Asia-Pacific Human Milk Oligosaccharides (HMO) Sales Forecast by Country (2027-2032) & (Tons) Table 131. Asia-Pacific Human Milk Oligosaccharides (HMO) Sales Market Share Forecast by Country (2027-2032) Table 132. Asia-Pacific Human Milk Oligosaccharides (HMO) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. Asia-Pacific Human Milk Oligosaccharides (HMO) Market Size by Country (2021-2026) & (US$ Million) Table 134. Asia-Pacific Human Milk Oligosaccharides (HMO) Market Share by Country (2021-2026) Table 135. Asia-Pacific Human Milk Oligosaccharides (HMO) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. Asia-Pacific Human Milk Oligosaccharides (HMO) Market Share Forecast by Country (2027-2032) Table 137. Latin America Human Milk Oligosaccharides (HMO) Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 138. Latin America Human Milk Oligosaccharides (HMO) Sales by Country (2021-2026) & (Tons) Table 139. Latin America Human Milk Oligosaccharides (HMO) Sales Market Share by Country (2021-2026) Table 140. Latin America Human Milk Oligosaccharides (HMO) Sales Forecast by Country (2027-2032) & (Tons) Table 141. Latin America Human Milk Oligosaccharides (HMO) Sales Market Share Forecast by Country (2027-2032) Table 142. Latin America Human Milk Oligosaccharides (HMO) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Latin America Human Milk Oligosaccharides (HMO) Market Size by Country (2021-2026) & (US$ Million) Table 144. Latin America Human Milk Oligosaccharides (HMO) Market Share by Country (2021-2026) Table 145. Latin America Human Milk Oligosaccharides (HMO) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Latin America Human Milk Oligosaccharides (HMO) Market Share Forecast by Country (2027-2032) Table 147. Middle East and Africa Human Milk Oligosaccharides (HMO) Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 148. Middle East and Africa Human Milk Oligosaccharides (HMO) Sales by Country (2021-2026) & (Tons) Table 149. Middle East and Africa Human Milk Oligosaccharides (HMO) Sales Market Share by Country (2021-2026) Table 150. Middle East and Africa Human Milk Oligosaccharides (HMO) Sales Forecast by Country (2027-2032) & (Tons) Table 151. Middle East and Africa Human Milk Oligosaccharides (HMO) Sales Market Share Forecast by Country (2027-2032) Table 152. Middle East and Africa Human Milk Oligosaccharides (HMO) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Middle East and Africa Human Milk Oligosaccharides (HMO) Market Size by Country (2021-2026) & (US$ Million) Table 154. Middle East and Africa Human Milk Oligosaccharides (HMO) Market Share by Country (2021-2026) Table 155. Middle East and Africa Human Milk Oligosaccharides (HMO) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Middle East and Africa Human Milk Oligosaccharides (HMO) Market Share Forecast by Country (2027-2032) Table 157. Key Raw Materials Table 158. Raw Materials Key Suppliers Table 159. Human Milk Oligosaccharides (HMO) Distributors List Table 160. Human Milk Oligosaccharides (HMO) Customers List Table 161. Research Programs/Design for This Report Table 162. Authors List of This Report Table 163. Secondary Sources Table 164. Primary Sources List of Figures Figure 1. Human Milk Oligosaccharides (HMO) Image Figure 2. Global Human Milk Oligosaccharides (HMO) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Milk Oligosaccharides (HMO) Market Size (2021-2032) & (US$ Million) Figure 4. Global Human Milk Oligosaccharides (HMO) Sales (2021-2032) & (Tons) Figure 5. 2'-FL & 3-FL Image Figure 6. Global 2'-FL & 3-FL Sales YoY Growth (2021-2032) & (Tons) Figure 7. Sialyllactose Image Figure 8. Global Sialyllactose Sales YoY Growth (2021-2032) & (Tons) Figure 9. LNT & LNnT Image Figure 10. Global LNT & LNnT Sales YoY Growth (2021-2032) & (Tons) Figure 11. Global Human Milk Oligosaccharides (HMO) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Human Milk Oligosaccharides (HMO) Market Share by Type 2025 VS 2032 Figure 13. North America Human Milk Oligosaccharides (HMO) Sales Market Share in Volume by Type in 2025 Figure 14. North America Human Milk Oligosaccharides (HMO) Sales Market Share in Value by Type in 2025 Figure 15. Europe Human Milk Oligosaccharides (HMO) Sales Market Share in Volume by Type in 2025 Figure 16. Europe Human Milk Oligosaccharides (HMO) Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Human Milk Oligosaccharides (HMO) Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Human Milk Oligosaccharides (HMO) Sales Market Share in Value by Type in 2025 Figure 19. Latin America Human Milk Oligosaccharides (HMO) Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Human Milk Oligosaccharides (HMO) Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Human Milk Oligosaccharides (HMO) Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Human Milk Oligosaccharides (HMO) Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Human Milk Oligosaccharides (HMO) Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Infant Formula Image Figure 26. Global Infant Formula Sales YoY Growth (2021-2032) & (Tons) Figure 27. Functional Food & Beverages Image Figure 28. Global Functional Food & Beverages Sales YoY Growth (2021-2032) & (Tons) Figure 29. Food/Medical Supplements Image Figure 30. Global Food/Medical Supplements Sales YoY Growth (2021-2032) & (Tons) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (Tons) Figure 33. Global Human Milk Oligosaccharides (HMO) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Human Milk Oligosaccharides (HMO) Market Share by Application 2025 VS 2032 Figure 35. North America Human Milk Oligosaccharides (HMO) Sales Market Share in Volume by Application in 2025 Figure 36. North America Human Milk Oligosaccharides (HMO) Sales Market Share in Value by Application in 2025 Figure 37. Europe Human Milk Oligosaccharides (HMO) Sales Market Share in Volume by Application in 2025 Figure 38. Europe Human Milk Oligosaccharides (HMO) Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Human Milk Oligosaccharides (HMO) Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Human Milk Oligosaccharides (HMO) Sales Market Share in Value by Application in 2025 Figure 41. Latin America Human Milk Oligosaccharides (HMO) Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Human Milk Oligosaccharides (HMO) Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Human Milk Oligosaccharides (HMO) Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Human Milk Oligosaccharides (HMO) Sales Market Share in Value by Application in 2025 Figure 45. North America Human Milk Oligosaccharides (HMO) Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 46. North America Human Milk Oligosaccharides (HMO) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Human Milk Oligosaccharides (HMO) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Human Milk Oligosaccharides (HMO) Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Human Milk Oligosaccharides (HMO) Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 50. Europe Human Milk Oligosaccharides (HMO) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Human Milk Oligosaccharides (HMO) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Human Milk Oligosaccharides (HMO) Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Human Milk Oligosaccharides (HMO) Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 54. Asia-Pacific Human Milk Oligosaccharides (HMO) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Human Milk Oligosaccharides (HMO) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Human Milk Oligosaccharides (HMO) Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Human Milk Oligosaccharides (HMO) Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 58. Latin America Human Milk Oligosaccharides (HMO) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Human Milk Oligosaccharides (HMO) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Human Milk Oligosaccharides (HMO) Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Human Milk Oligosaccharides (HMO) Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 62. Middle East and Africa Human Milk Oligosaccharides (HMO) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Human Milk Oligosaccharides (HMO) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Human Milk Oligosaccharides (HMO) Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Human Milk Oligosaccharides (HMO) Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Human Milk Oligosaccharides (HMO) Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 2'-FL & 3-FL
  • Sialyllactose
  • LNT & LNnT
Applications
  • Infant Formula
  • Functional Food & Beverages
  • Food/Medical Supplements
  • Others
Companies covered
  • Abbott
  • Inbiose
  • Glycom
  • Chr. Hansen (Jennewein)
  • Elicityl SA
  • ZuChem
  • Dextra Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Human Milk Oligosaccharides (HMO) Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Human Milk Oligosaccharides (HMO) Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Human Milk Oligosaccharides (HMO) Market by Type
  6. 1.3.1 2'-FL & 3-FL
  7. 1.3.2 Sialyllactose
  8. 1.3.3 LNT & LNnT
  9. 1.4 Global Human Milk Oligosaccharides (HMO) Market Size by Type
  10. 1.4.1 Global Human Milk Oligosaccharides (HMO) Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Human Milk Oligosaccharides (HMO) Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Human Milk Oligosaccharides (HMO) Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Human Milk Oligosaccharides (HMO) Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Human Milk Oligosaccharides (HMO) Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Human Milk Oligosaccharides (HMO) Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Human Milk Oligosaccharides (HMO) Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Human Milk Oligosaccharides (HMO) Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Human Milk Oligosaccharides (HMO) Industry Trends
  2. 2.2 Human Milk Oligosaccharides (HMO) Industry Drivers
  3. 2.3 Human Milk Oligosaccharides (HMO) Industry Opportunities and Challenges
  4. 2.4 Human Milk Oligosaccharides (HMO) Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Human Milk Oligosaccharides (HMO) Revenue (2021-2026)
  2. 3.2 Global Top Players by Human Milk Oligosaccharides (HMO) Sales (2021-2026)
  3. 3.3 Global Top Players by Human Milk Oligosaccharides (HMO) Price (2021-2026)
  4. 3.4 Global Human Milk Oligosaccharides (HMO) Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Human Milk Oligosaccharides (HMO) Major Company Production Sites & Headquarters
  6. 3.6 Global Human Milk Oligosaccharides (HMO) Company, Product Type & Application
  7. 3.7 Global Human Milk Oligosaccharides (HMO) Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Human Milk Oligosaccharides (HMO) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Human Milk Oligosaccharides (HMO) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Human Milk Oligosaccharides (HMO) Tier 1, Tier 2, and Tier 3
4 Human Milk Oligosaccharides (HMO) Regional Status and Outlook
  1. 4.1 Global Human Milk Oligosaccharides (HMO) Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Human Milk Oligosaccharides (HMO) Historic Market Size by Region
  3. 4.2.1 Global Human Milk Oligosaccharides (HMO) Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Human Milk Oligosaccharides (HMO) Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Human Milk Oligosaccharides (HMO) Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Human Milk Oligosaccharides (HMO) Forecasted Market Size by Region
  7. 4.3.1 Global Human Milk Oligosaccharides (HMO) Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Human Milk Oligosaccharides (HMO) Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Human Milk Oligosaccharides (HMO) Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Human Milk Oligosaccharides (HMO) by Application
  1. 5.1 Human Milk Oligosaccharides (HMO) Market by Application
  2. 5.1.1 Infant Formula
  3. 5.1.2 Functional Food & Beverages
  4. 5.1.3 Food/Medical Supplements
  5. 5.1.4 Others
  6. 5.2 Global Human Milk Oligosaccharides (HMO) Market Size by Application
  7. 5.2.1 Global Human Milk Oligosaccharides (HMO) Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Human Milk Oligosaccharides (HMO) Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Human Milk Oligosaccharides (HMO) Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Human Milk Oligosaccharides (HMO) Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Human Milk Oligosaccharides (HMO) Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Human Milk Oligosaccharides (HMO) Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Human Milk Oligosaccharides (HMO) Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Human Milk Oligosaccharides (HMO) Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Abbott
  2. 6.1.1 Abbott Company Information
  3. 6.1.2 Abbott Business Overview
  4. 6.1.3 Abbott Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Abbott Human Milk Oligosaccharides (HMO) Product Portfolio
  6. 6.1.5 Abbott Recent Developments
  7. 6.2 Inbiose
  8. 6.2.1 Inbiose Company Information
  9. 6.2.2 Inbiose Business Overview
  10. 6.2.3 Inbiose Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Inbiose Human Milk Oligosaccharides (HMO) Product Portfolio
  12. 6.2.5 Inbiose Recent Developments
  13. 6.3 Glycom
  14. 6.3.1 Glycom Company Information
  15. 6.3.2 Glycom Business Overview
  16. 6.3.3 Glycom Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Glycom Human Milk Oligosaccharides (HMO) Product Portfolio
  18. 6.3.5 Glycom Recent Developments
  19. 6.4 Chr. Hansen (Jennewein)
  20. 6.4.1 Chr. Hansen (Jennewein) Company Information
  21. 6.4.2 Chr. Hansen (Jennewein) Business Overview
  22. 6.4.3 Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Product Portfolio
  24. 6.4.5 Chr. Hansen (Jennewein) Recent Developments
  25. 6.5 Elicityl SA
  26. 6.5.1 Elicityl SA Company Information
  27. 6.5.2 Elicityl SA Business Overview
  28. 6.5.3 Elicityl SA Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Elicityl SA Human Milk Oligosaccharides (HMO) Product Portfolio
  30. 6.5.5 Elicityl SA Recent Developments
  31. 6.6 ZuChem
  32. 6.6.1 ZuChem Company Information
  33. 6.6.2 ZuChem Business Overview
  34. 6.6.3 ZuChem Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 ZuChem Human Milk Oligosaccharides (HMO) Product Portfolio
  36. 6.6.5 ZuChem Recent Developments
  37. 6.7 Dextra Laboratories
  38. 6.7.1 Dextra Laboratories Company Information
  39. 6.7.2 Dextra Laboratories Business Overview
  40. 6.7.3 Dextra Laboratories Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Dextra Laboratories Human Milk Oligosaccharides (HMO) Product Portfolio
  42. 6.7.5 Dextra Laboratories Recent Developments
7 North America by Country
  1. 7.1 North America Human Milk Oligosaccharides (HMO) Sales by Country
  2. 7.1.1 North America Human Milk Oligosaccharides (HMO) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Human Milk Oligosaccharides (HMO) Sales by Country (2021-2026)
  4. 7.1.3 North America Human Milk Oligosaccharides (HMO) Sales Forecast by Country (2027-2032)
  5. 7.2 North America Human Milk Oligosaccharides (HMO) Market Size by Country
  6. 7.2.1 North America Human Milk Oligosaccharides (HMO) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Human Milk Oligosaccharides (HMO) Market Size by Country (2021-2026)
  8. 7.2.3 North America Human Milk Oligosaccharides (HMO) Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Human Milk Oligosaccharides (HMO) Sales by Country
  2. 8.1.1 Europe Human Milk Oligosaccharides (HMO) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Human Milk Oligosaccharides (HMO) Sales by Country (2021-2026)
  4. 8.1.3 Europe Human Milk Oligosaccharides (HMO) Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Human Milk Oligosaccharides (HMO) Market Size by Country
  6. 8.2.1 Europe Human Milk Oligosaccharides (HMO) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Human Milk Oligosaccharides (HMO) Market Size by Country (2021-2026)
  8. 8.2.3 Europe Human Milk Oligosaccharides (HMO) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Human Milk Oligosaccharides (HMO) Sales by Country
  2. 9.1.1 Asia-Pacific Human Milk Oligosaccharides (HMO) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Human Milk Oligosaccharides (HMO) Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Human Milk Oligosaccharides (HMO) Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Human Milk Oligosaccharides (HMO) Market Size by Country
  6. 9.2.1 Asia-Pacific Human Milk Oligosaccharides (HMO) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Human Milk Oligosaccharides (HMO) Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Human Milk Oligosaccharides (HMO) Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Human Milk Oligosaccharides (HMO) Sales by Country
  2. 10.1.1 South America Human Milk Oligosaccharides (HMO) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Human Milk Oligosaccharides (HMO) Sales by Country (2021-2026)
  4. 10.1.3 South America Human Milk Oligosaccharides (HMO) Sales Forecast by Country (2027-2032)
  5. 10.2 South America Human Milk Oligosaccharides (HMO) Market Size by Country
  6. 10.2.1 South America Human Milk Oligosaccharides (HMO) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Human Milk Oligosaccharides (HMO) Market Size by Country (2021-2026)
  8. 10.2.3 South America Human Milk Oligosaccharides (HMO) Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Human Milk Oligosaccharides (HMO) Sales by Country
  2. 11.1.1 Middle East and Africa Human Milk Oligosaccharides (HMO) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Human Milk Oligosaccharides (HMO) Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Human Milk Oligosaccharides (HMO) Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Human Milk Oligosaccharides (HMO) Market Size by Country
  6. 11.2.1 Middle East and Africa Human Milk Oligosaccharides (HMO) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Human Milk Oligosaccharides (HMO) Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Human Milk Oligosaccharides (HMO) Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Human Milk Oligosaccharides (HMO) Value Chain Analysis
  2. 12.1.1 Human Milk Oligosaccharides (HMO) Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Human Milk Oligosaccharides (HMO) Production Mode & Process
  7. 12.2 Human Milk Oligosaccharides (HMO) Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Human Milk Oligosaccharides (HMO) Distributors
  10. 12.2.3 Human Milk Oligosaccharides (HMO) Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst